Possible predictors of histopathological response to neoadjuvant chemoradiotherapy for rectal cancer

被引：0
|
作者：
Robert Farkas
Eva Pozsgai
Andrew V. Schally
Andras Szigeti
Edit Szigeti
Zoltan Laszlo
Andras Papp
Eva Gomori
Laszlo Mangel
Peter O. Horvath
Szabolcs Bellyei
机构：
[1] University of Pécs,Department of Oncology
[2] University of Pécs,Department of Biochemistry and Medical Chemistry
[3] Veterans Affairs Medical Center and South Florida Veterans Affairs Foundation for Research and Education,Department of Surgery
[4] University of Pécs,Department of Pathology
[5] University of Pécs,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2012年 / 138卷
关键词：
Neoadjuvant chemoradiotherapy; Rectal cancer; Hsp90; GHRH-R; Predictive marker of tumor regression; Prediction of response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：387 / 395
页数：8
相关论文
共 50 条
  • [1] Possible predictors of histopathological response to neoadjuvant chemoradiotherapy for rectal cancer
    Farkas, Robert
    Pozsgai, Eva
    Schally, Andrew V.
    Szigeti, Andras
    Szigeti, Edit
    Laszlo, Zoltan
    Papp, Andras
    Gomori, Eva
    Mangel, Laszlo
    Horvath, Peter O.
    Bellyei, Szabolcs
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2012, 138 (03) : 387 - 395
  • [2] Predictors of pathological complete response following neoadjuvant chemoradiotherapy for rectal cancer
    Mehraj, Asif
    Baba, Arshad A.
    Khan, Bushra
    Khan, Mudassir Ahmad
    Wani, Rauf A.
    Parray, Fazl Q.
    Chowdri, Nisar A.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (09) : S391 - S396
  • [3] Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer
    Eisar Al-Sukhni
    Kristopher Attwood
    David M. Mattson
    Emmanuel Gabriel
    Steven J. Nurkin
    Annals of Surgical Oncology, 2016, 23 : 1177 - 1186
  • [4] Morphologic predictors of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
    Zhang, Chongda
    Ye, Feng
    Liu, Yuan
    Ouyang, Han
    Zhao, Xinming
    Zhang, Hongmei
    ONCOTARGET, 2018, 9 (04) : 4862 - 4874
  • [5] Pathologic complete response in patients with neoadjuvant chemoradiotherapy for rectal cancer
    Espinola M, Daniella
    Molina P, Maria E.
    Bellolio R, Felipe
    Gellona, Jose, V
    Bustos C, Mariza
    Zuniga D, Alvaro
    REVISTA CHILENA DE CIRUGIA, 2013, 65 (04): : 333 - 337
  • [6] A Study of Inflammation-Based Predictors of Tumor Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
    Krauthamer, Mark
    Rouvinov, Keren
    Ariad, Samuel
    Man, Sofia
    Walfish, Shlomo
    Pinsk, Ilia
    Sztarker, Ignatio
    Charkovsky, Tatiana
    Lavrenkov, Konstantin
    ONCOLOGY, 2013, 85 (01) : 27 - 32
  • [7] Predictive Factors of Complete Response to Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer
    Carlomagno, Chiara
    Pepe, Stefano
    D'Armiento, Francesco Paolo
    D'Armiento, Maria
    Cannella, Lucia
    De Stefano, Alfonso
    Crispo, Anna
    Giordano, Marcella
    De Placido, Sabino
    ONCOLOGY, 2010, 78 (5-6) : 369 - 375
  • [8] Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
    Marinkovic, Mladen
    Stojanovic-Rundic, Suzana
    Stanojevic, Aleksandra
    Ostojic, Marija
    Gavrilovic, Dusica
    Jankovic, Radmila
    Maksimovic, Natasa
    Stroggilos, Rafael
    Zoidakis, Jerome
    Castellvi-Bel, Sergi
    Fijneman, Remond J. A.
    Cavic, Milena
    FRONTIERS IN GENETICS, 2023, 14
  • [9] Rectal cancer: Neoadjuvant chemoradiotherapy
    Roedel, Claus
    Hofheinz, Ralf
    Fokas, Emmanouil
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2016, 30 (04) : 629 - 639
  • [10] Predictors and Risk Factors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Population-Based Analysis
    Tan, Yinuo
    Fu, Dongliang
    Liu, Dan
    Kong, Xiangxing
    Jiang, Kai
    Chen, Liubo
    Yuan, Ying
    Ding, Kefeng
    FRONTIERS IN ONCOLOGY, 2019, 9
12345